<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1205</volume><submitter>Lopez-Valls M</submitter><funding>Instituto de Salud Carlos III</funding><funding>Ministerio de Economía y Competitividad</funding><pubmed_abstract>The COVID-19 pandemic has brought to light the need for fast and sensitive detection methods to prevent the spread of pathogens. The scientific community is making a great effort to design new molecular detection methods suitable for fast point-of-care applications. In this regard, a variety of approaches have been developed or optimized, including isothermal amplification of viral nucleic acids, CRISPR-mediated target recognition, and read-out systems based on nanomaterials. Herein, we present CASCADE (CRISPR/CAS-based Colorimetric nucleic Acid DEtection), a sensing system for fast and specific naked-eye detection of SARS-CoV-2 RNA. In this approach, viral RNA is recognized by the LwaCas13a CRISPR protein, which activates its collateral RNase activity. Upon target recognition, Cas13a clea</pubmed_abstract><journal>Analytica chimica acta</journal><pagination>339749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8939626</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles.</pubmed_title><pmcid>PMC8939626</pmcid><pubmed_authors>Castellanos M</pubmed_authors><pubmed_authors>Lopez-Valls M</pubmed_authors><pubmed_authors>Rodriguez-Diaz C</pubmed_authors><pubmed_authors>Canton R</pubmed_authors><pubmed_authors>Coloma R</pubmed_authors><pubmed_authors>Abreu M</pubmed_authors><pubmed_authors>Miranda R</pubmed_authors><pubmed_authors>Somoza A</pubmed_authors><pubmed_authors>Martinez-Garay C</pubmed_authors><pubmed_authors>Escalona-Noguero C</pubmed_authors><pubmed_authors>Milan-Rois P</pubmed_authors><pubmed_authors>Pardo D</pubmed_authors><pubmed_authors>Galan JC</pubmed_authors><pubmed_authors>Sot B</pubmed_authors></additional><is_claimable>false</is_claimable><name>CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles.</name><description>The COVID-19 pandemic has brought to light the need for fast and sensitive detection methods to prevent the spread of pathogens. The scientific community is making a great effort to design new molecular detection methods suitable for fast point-of-care applications. In this regard, a variety of approaches have been developed or optimized, including isothermal amplification of viral nucleic acids, CRISPR-mediated target recognition, and read-out systems based on nanomaterials. Herein, we present CASCADE (CRISPR/CAS-based Colorimetric nucleic Acid DEtection), a sensing system for fast and specific naked-eye detection of SARS-CoV-2 RNA. In this approach, viral RNA is recognized by the LwaCas13a CRISPR protein, which activates its collateral RNase activity. Upon target recognition, Cas13a clea</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-26T04:40:34.889Z</modification><creation>2025-04-06T11:13:01.457Z</creation></dates><accession>S-EPMC8939626</accession><cross_references><pubmed>35414398</pubmed><doi>10.1016/j.aca.2022.339749</doi></cross_references></HashMap>